News Daily News ¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación? Michael O'Riordan March 09, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Daily News ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy Yael L. Maxwell December 27, 2012